Luye Pharma boosts convertible to $300m
![Pills_medicine_230px](https://assets.euromoneydigital.com/dims4/default/4e93c61/2147483647/strip/true/crop/230x150+0+0/resize/840x548!/quality/90/?url=http%3A%2F%2Feuromoney-brightspot.s3.amazonaws.com%2Faf%2F92%2F23456021c1c4426ef7ba54a92259%2Fpills-2-230px.jpg)
Hong Kong-listed Luye Pharma Group sealed a convertible bond on Monday night, raising $300m from the increased deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: